Skip to content
20 June 2026

Oprah Winfrey’s transformative journey with GLP-1 drugs and body image

Oprah Winfrey shares her insights on weight loss and societal perceptions of thinness.

Oprah Winfrey discussing body image and GLP-1 drugs
Explore Oprah Winfrey's transformative experience with GLP-1 drugs and body image.

Understanding GLP-1 drugs and their impact

In recent discussions, media icon Oprah Winfrey opened up about her experience with GLP-1 medications, specifically Ozempic and Wegovy, which are primarily used for managing type 2 diabetes but have gained popularity for their weight loss benefits. Winfrey’s candid reflections on her journey with these drugs highlight a significant shift in her understanding of body image and the societal perceptions surrounding weight. She emphasizes that her initial beliefs about thin individuals—associating their body type with greater willpower and healthier eating habits—were fundamentally flawed.

The revelation of ‘food noise’

During a recent episode of “The Oprah Podcast,” Winfrey shared her realization that the concept of willpower in relation to food is often misunderstood. She described how, after starting her GLP-1 treatment, she recognized that many thin people do not experience the same intrusive thoughts about food, which she refers to as “food noise.” This absence of constant hunger thoughts allows them to eat intuitively, stopping when they are full. Winfrey’s insights challenge the long-held belief that weight management is solely a matter of self-control, shedding light on the complexities of obesity as a medical condition.

Breaking the stigma of obesity

Winfrey’s journey also touches on the stigma associated with obesity, a topic she has faced publicly throughout her career. She candidly discussed the exploitation she experienced from tabloids and comedians, which contributed to her feelings of shame regarding her weight. This societal pressure often leads individuals to internalize blame for their condition, a sentiment Winfrey has grappled with for years. However, her recent experiences have led her to a profound understanding that obesity is not merely a failure of willpower but a complex interplay of biological and psychological factors.

In her words, “Obesity is a disease. It’s not about willpower — it’s about the brain.” This perspective is crucial in fostering a more compassionate understanding of those struggling with weight issues. Winfrey’s advocacy for recognizing obesity as a medical condition rather than a personal failing is a powerful message that resonates with many, especially in a society that often stigmatizes those who do not conform to conventional body standards.

World Cup 2026

Upcoming matches

Today
Netherlands
13:00EDTGroup F
Sweden
Germany
16:00EDTGroup E
Ivory Coast
Ecuador
20:00EDTGroup E
Curaçao
Tomorrow
Tunisia
00:00EDTGroup F
Japan

Results

Fri 19 Jun
Turkey
01FT · Group D
Paraguay
Brazil
30FT · Group C
Haiti
Scotland
01FT · Group C
Morocco
USA
20FT · Group D
Australia
Updated 06:52 EDT